BYOT.L

Byotrol Plc
Byotrol PLC - Result of AGM
13th September 2023, 14:33
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3556M
Byotrol PLC
13 September 2023
 

 

Byotrol plc

("Byotrol" or the "Company")

Result of Annual General Meeting ("AGM")

 

Byotrol plc (AIM: BYOT), the developer of anti-microbial hygiene technologies, announces that all resolutions proposed at the AGM held earlier today, as set out in the Notice of Annual General Meeting, were duly passed.

The total proxy votes cast prior to the AGM were as follows:

 

Resolution

In favour


Discretion

 

Against


Withheld *


Votes

%

Votes

%

Votes

%

Votes











 






1

66,180,547

99.96%

1,500

0.01%

20,431

0.03%

1,339,665

2

64,703,257

95.88%

 

 

2,783,623

4.12%

55,263

3

64,681,263

95.84%

 

 

2,805,617

4.16%

55,263

4

66,189,047

98.11%

 

 

1,273,033

1.89%

80,063

5

65,854,428

97.57%

 

 

1,638,901

2.43%

48,814

6

64,561,174

95.66%

 

 

2,932,155

4.34%

48,814

7

66,077,089

97.90%

 

 

1,419,791

2.10%

45,263



 






*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "in favour" or "against" the resolutions.

 

Change of Name of Nominated Adviser and Broker

 

The Company also announces that its Nominated Adviser and Sole Broker has changed its name to Cavendish Capital Markets Limited following completion of its own corporate merger.

 

 

Enquiries:

 

Byotrol Plc


Trevor Francis - Chairman

Vivan Pinto - Chief Executive Officer

+44 (0)1925 742 000

Chris Sedwell - Chief Financial Officer




Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Geoff Nash / George Dollemore - Corporate Finance


Nigel Birks / Harriet Ward - ECM




Flagstaff Strategic and Investor Communications

+44 (0)20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon                                              

 

byotrol@flagstaffcomms.com

 

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFLFVSAIIVLIV ]]>
TwitterFacebookLinkedIn